InspireMD Signs Distribution Agreement with Arteriae

Biotech Investing

InspireMD signed an agreement with Arteriae, a medical distributor leader in Poland, to distribute CGuard Embolic Prevention System.

InspireMD (NYSEMKT:NSPR) signed an agreement with Arteriae, a medical distributor leader in Poland, to distribute CGuard Embolic Prevention System.
As quoted in the press release:

Agustin Gago, EVP and Chief Commercial Officer of InspireMD, commented, “We are delighted to partner with Arteriae, a leading device distributor in Poland. The agreement includes minimum required purchases, reinforcing Arteriae’s confidence in our device. Arteriae brings strong relationships with the top key opinion leaders and physicians across all relevant clinical specialties and plans to expand its sales force to focus on CGuard™ EPS. Importantly, this agreement further illustrates our success in expanding our direct distribution model in markets previously covered by our former distributor.”
Mrs. Joanna Niedzielska, CEO of Arteriae, noted, “We look forward to aggressively launching CGuard™ in Poland. Given the important safety advantages of CGuard™ that have been demonstrated to date, our near-term goal is to capture a significant share of the Polish market and we believe this device will soon become standard of care.”

Click here to read the full press release.


The Conversation (0)